These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


190 related items for PubMed ID: 7734899

  • 1. Prediction of the growth response of short prepubertal children treated with growth hormone. Swedish Paediatric Study Group for GH treatment.
    Kriström B, Karlberg J, Albertsson-Wikland K.
    Acta Paediatr; 1995 Jan; 84(1):51-7. PubMed ID: 7734899
    [Abstract] [Full Text] [Related]

  • 2. Predictors of first-year growth response to a fixed-dose growth hormone treatment in children born small for gestational age: results of an open-label, multicenter trial in the United States.
    Rapaport R, Saenger P, Wajnrajch MP, Pfizer SGA Collaborative Study Group.
    J Pediatr Endocrinol Metab; 2008 May; 21(5):411-22. PubMed ID: 18655522
    [Abstract] [Full Text] [Related]

  • 3. Responses to growth hormone (GH) therapy in short children with normal GH secretion and no bone age delay: an analysis of potential factors affecting their response to rhGH therapy. A controlled study.
    Soliman AT, Elawwa A, Itani M, Jour C, De Sanctis V.
    Acta Biomed; 2019 Sep 23; 90(8-S):43-51. PubMed ID: 31544806
    [Abstract] [Full Text] [Related]

  • 4. Growth hormone (GH) dose-dependent IGF-I response relates to pubertal height gain.
    Lundberg E, Kriström B, Jonsson B, Albertsson-Wikland K, study group.
    BMC Endocr Disord; 2015 Dec 18; 15():84. PubMed ID: 26682747
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Age at growth hormone therapy start and first-year responsiveness to growth hormone are major determinants of height outcome in idiopathic short stature.
    Ranke MB, Lindberg A, Price DA, Darendeliler F, Albertsson-Wikland K, Wilton P, Reiter EO, KIGS International Board.
    Horm Res; 2007 Dec 18; 68(2):53-62. PubMed ID: 17228181
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Final height data, body composition and glucose metabolism in growth hormone-treated short children born small for gestational age.
    Hokken-Koelega AC, van Pareren Y, Sas T, Arends N.
    Horm Res; 2003 Dec 18; 60 Suppl 3():113-4. PubMed ID: 14671407
    [Abstract] [Full Text] [Related]

  • 13. Adult height after long-term, continuous growth hormone (GH) treatment in short children born small for gestational age: results of a randomized, double-blind, dose-response GH trial.
    Van Pareren Y, Mulder P, Houdijk M, Jansen M, Reeser M, Hokken-Koelega A.
    J Clin Endocrinol Metab; 2003 Aug 18; 88(8):3584-90. PubMed ID: 12915640
    [Abstract] [Full Text] [Related]

  • 14. Long-term results of growth hormone therapy in children with short stature, subnormal growth rate and normal growth hormone response to secretagogues. Dutch Growth Hormone Working Group.
    Wit JM, Boersma B, de Muinck Keizer-Schrama SM, Nienhuis HE, Oostdijk W, Otten BJ, Delemarre-Van de Waal HA, Reeser M, Waelkens JJ, Rikken B.
    Clin Endocrinol (Oxf); 1995 Apr 18; 42(4):365-72. PubMed ID: 7750190
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Response to growth hormone with respect to pubertal status on increased dose in idiopathic growth hormone deficiency: an analysis of Turkish children in the KIGS database (Pfizer International Growth Study).
    Darendeliler F, Berberoğlu M, Ocal G, Adiyaman P, Bundak R, Günöz H, Baş F, Darcan S, Gökşen D, Arslanoğlu I, Yildiz M, Ercan O, Ercan G, Ozerkan E, Can S, Böber E, Adal E, Sarikaya S, Dallar Y, Siklar Z, Bircan I, Bideci A, Yüksel B, Büyükgebiz A.
    J Pediatr Endocrinol Metab; 2005 Oct 18; 18(10):949-54. PubMed ID: 16355808
    [Abstract] [Full Text] [Related]

  • 17. IGF-I and IGF binding protein-3 levels during initial GH dosage step-up are indicators of GH sensitivity in GH-deficient children and short children born small for gestational age.
    Ranke MB, Traunecker R, Martin DD, Schweizer R, Schwarze CP, Wollmann HA, Binder G.
    Horm Res; 2005 Oct 18; 64(2):68-76. PubMed ID: 16113581
    [Abstract] [Full Text] [Related]

  • 18. Growth hormone response to a standardised exercise test in relation to puberty and stature.
    Greene SA, Torresani T, Prader A.
    Arch Dis Child; 1987 Jan 18; 62(1):53-6. PubMed ID: 3813636
    [Abstract] [Full Text] [Related]

  • 19. Growth hormone (GH) dosing during catch-up growth guided by individual responsiveness decreases growth response variability in prepubertal children with GH deficiency or idiopathic short stature.
    Kriström B, Aronson AS, Dahlgren J, Gustafsson J, Halldin M, Ivarsson SA, Nilsson NO, Svensson J, Tuvemo T, Albertsson-Wikland K.
    J Clin Endocrinol Metab; 2009 Feb 18; 94(2):483-90. PubMed ID: 19001519
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.